Bioadvance Capital's annual revenue was $7.8M in tax year 2024, reported on their IRS Form 990. They spent $2.7M in total expenses. 61% went to programs and services.
Bioadvance Capital spent $2.7M in tax year 2024, according to their IRS Form 990 filing.
Bioadvance Capital spent $1.6M (61% of expenses) on programs and services in tax year 2024.
Bioadvance Capital's overhead in tax year 2024 includes administrative (39%) of their expenses.
Bioadvance Capital had net assets of $80.3M as of the end of tax year 2024.
Track Bioadvance Capital
Follow to get their new filings, financial changes and grants as they post.
Leave your email and we’ll let you know when you can finish signing in and follow the organization.
Try signing in anyway →